Anis Fahandej-Sadi’s Post

View profile for Anis Fahandej-Sadi, graphic

The top Biotech & Pharma stories in one daily email - TLDR Biotech 🧬💊 | Founder, Head Editor | Bespoke Biotech & Pharma Market Research 📊🔎

TLDR Biotech for June 26 - 27 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭: Novo Nordisk buys 2seventy bio’s Hemophilia A asset for $40M 🤝 + 1 more story 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬: Silence Therapeutics reports encouraging early Ph1 blood disorder data 🩸 + 2 more stories 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐋𝐚𝐮𝐧𝐜𝐡𝐞𝐬: WayPoint Bio launches to "test hundreds [of cell therapies] at once" 🤯 𝐅𝐮𝐧𝐝𝐫𝐚𝐢𝐬𝐞𝐬: Holoclara’s worm-derived therapies raise a $16M Series A 🪱 + 5 more stories 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬: Vigil Therapeutics receive $40M strategic investment from Sanofi 💼 𝐌𝐞𝐫𝐠𝐞𝐫𝐬 & 𝐀𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧𝐬: AbbVie brings the heat, buys Celsius Therapeutics for $250M cash 🔥 + 3 more stories 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬: Kite Pharma signs on to assess Cellares’ cell therapy manufacturing platform 🤖 𝐏𝐨𝐥𝐢𝐭𝐢𝐜𝐬 & 𝐏𝐨𝐥𝐢𝐜𝐲: Medicare inches closer to covering weight loss drugs 💊 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐋𝐚𝐮𝐧𝐜𝐡𝐞𝐬: Eisai, Biogen's Leqembi launches in China 🚀 All this and more in today's TLDR Biotech newsletter - link to the latest issue: https://lnkd.in/gfw7pkVK Or subscribe to get it straight to your inbox: https://lnkd.in/gh68uhTQ #tldrbiotech #biotechnews #pharmanews

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics